Mechanistically, our data suggest FTO promotes the proliferation and migration of ccRCC through preventing degradation of PDK1 mRNA induced by YTHDF2 in an m6A-dependent mechanism. The gene discussed is PDK1; the disease is nonpapillary renal cell carcinoma.